Sharon Barber-Lui

Sharon Barber-Lui has more than 25 years of diverse experiences at large and emerging biopharmaceutical and major public accounting companies with strong life science innovation, entrepreneurship and business transformation activity. Most recently, she has served as Senior Vice President of Global Finance at EQRx, a biopharmaceutical company committed to innovative medicines for prevalent disease areas. In this role, she provided financial leadership to create and scale the infrastructure and operational capabilities for growth and commercialization. During her 22 years at Merck & Co. Inc., Sharon held several financial and operational related roles. She led Portfolio Market Strategy, Operations and Business Analytics at Merck & Co.’s U.S. Oncology business from 2019 through 2021, where she previously served as Chief Financial Officer of U.S. Oncology from 2014 to 2018. That business portfolio included KEYTRUDA®, innovative, mature, co-developed and co-commercialized products.

Sharon is a Board Member, Audit Committee Chairperson, and Transaction Committee Member at PureTech Health plc. She received her MBA in marketing and corporate entrepreneurship and her B.S. in accounting from Lehigh University.